Volrustomig (Anti-CTLA4 & PD-1)
Product Specifications
Synonyms
MEDI 5752
SKU
C00915-1mg
Target
CD markers
Applications
Transmembrane Transporters
Additionnal Information
Volrustomig is an engineered fragment crystallizable (Fc) domain, monovalent bispecific IgG1 monoclonal antibody targeting PD-1 and CTLA-4, key immune checkpoint receptors. It enhances T-cell activation and antitumor immunity, making it a promising immunotherapy for various cancers. M.W 146.77 kDa
Storage Conditions
-80°C (avoid freeze-thaw cycles)
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1177827-01 0.02 mg (E-Coli)
Recombinant Mycoplasma genitalium Cytidine deaminase (cdd)
Ask
View Details MBS1177827-02 0.1 mg (E-Coli)
Recombinant Mycoplasma genitalium Cytidine deaminase (cdd)
Ask
View Details MBS1177827-03 0.02 mg (Yeast)
Recombinant Mycoplasma genitalium Cytidine deaminase (cdd)
Ask
View Details MBS1177827-04 0.1 mg (Yeast)
Recombinant Mycoplasma genitalium Cytidine deaminase (cdd)
Ask
View Details